Body Composition Estimated by Bioelectrical Impedance Analysis in Patients with Acute Coronary Syndrome.

Launched by HOSPITAL DE CLINICAS JOSÉ DE SAN MARTÍN · Aug 15, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating the relationship between body composition and health outcomes in patients with acute coronary syndrome (ACS), which is a serious heart condition. Researchers want to understand how factors like body fat and muscle mass affect recovery and survival, especially since some studies have shown that obese patients with heart issues may actually have better outcomes than expected—a situation known as the "obesity paradox." By using a method called bioelectrical impedance analysis (BIA), which measures different components of body composition, the study aims to provide insights that could lead to more personalized treatments for patients with ACS.

To participate in this trial, individuals must be hospitalized in the Cardiovascular Care Unit with a diagnosis of acute coronary syndrome. The study is open to all genders and typically includes patients aged 65 to 74. If you or a family member is eligible, joining the study could involve undergoing assessments that measure body composition, helping researchers understand its impact on health outcomes like heart and kidney function. This research is taking place at a major hospital in Argentina and aims to contribute valuable knowledge to improve care for patients with heart conditions.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: All patients hospitalized in the Cardiovascular Care Unit with a diagnosis of acute coronary syndrome.
• • Exclusion Criteria: Decline to participate.